ALGS - Aligos Therapeutics GAAP EPS of -$0.89 misses by $0.06 March, 10 2022 04:31 PM Aligos Therapeutics Inc. Aligos Therapeutics press release (NASDAQ:ALGS): Q4 GAAP EPS of -$0.89 misses by $0.06. Q4 Cash , cash equivalents $205.8M For further details see: Aligos Therapeutics GAAP EPS of -$0.89 misses by $0.06